Allarity Therapeutics Inc (NASDAQ:ALLR) currently has a daily average trading volume of 2.81M but it saw 3291682 shares traded in last market. With a market cap of 4.66M USD, the company’s current market price of $1.05 came falling about -7.89 while comparing to the previous closing price of $1.14. In past 52 weeks, the stock remained buoying in the range of price level as high as $197.88 and as low as $0.68. In the recent trading on the day, stock has struck highest price mark of $0.9101 while lowest mark touched by it was $1.2.
Taking a look at 20-day trading activity of Allarity Therapeutics Inc (ALLR) gives us an average price of $0.9933, while its current price level is -99.47% below from 52-week high level whereas it is 54.98% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $1.0343 while that of 200 days or SMA-200 reads an average of $3.0336. A closer look into the stock’s movement over the week reveals that its volatility is standing at 17.80% during that period while stretching the period over a month that decreases to 16.35%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 52.90 which implies that the stock is in neutral territory.
Over the week, ALLR’s stock price is moving 9.38% up while it is 35.19% when we observe its performance for the past one month. Year-to-date it is -10.26% down and over the past year, the stock is showing a downside performance of -99.43%.
The company is expected to be releasing its next quarterly report on 2024-Nov-13, for which analysts forecasted an EPS of 0 while estimate for next year EPS is 0.
Currently, Allarity Therapeutics Inc’s total number of outstanding shares is 4.43M with 16.80% of that held by the insiders while 2.36% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -151.54% and return on equity (ROE) at -391.95%. Stock’s beta reads -0.12. Stock has a price to book (P/B) ratio of 0.22. Its return on asset (ROA) is -109.68% on average.
